Macroleuco

Macroleuco Dosage/Direction for Use

filgrastim

Manufacturer:

Dong-A

Distributor:

Metro Drug

Marketer:

Macropharma Corp
Full Prescribing Info
Dosage/Direction for Use
Cancer Patients Receiving Myelosuppressive Chemotherapy: In adult and children, the usual dosage for subcutaneous use is 100 ug/m2 (adult) and 50 ug/m2 (children) of Filgrastim (Macroleuco) once a daily for 10 days.
Administration should start following cancer chemotherapy (on the next day later). To patients in whose case subcutaneous injection is not appropriate due to bleeding tendency, etc, 100 ug/m2 of Filgrastim (Macroleuco) should be administered intravenously (including intravenous drip infusion) once daily. However, administration should be discontinued when the lowest neutrophil count increases to 5,000/mm3 after the period in which the lowest neutrophil count was observed.
Patients With Acute Myeloid Leukemia (AML) receiving Induction Chemotherapy: In adults and children, the usual dosage for intravenous use (including intravenous Drip infusion) is 200 ug/m2 of Filgrastim (Macroleuco) once daily.
Administration should start following cancer chemotherapy (on the next day or later) when myeloblasts have sufficiently decreased and are not observed in peripheral blood. However, administration should be discontinue when the neutrophil count increases to 5,000/mm3 after the period in which the lowest neutrophil count was observe
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in